Aspect Biosystems

Management

Tamer Mohamed

Co-founder & CEO

Konrad Walus

Co-founder & CTO

Connect

News

PRINTING LIVING HUMAN TISSUES

After developing a revolutionary technology that allows us to 3D-print living human tissues, we are now creating innovative drug testing platforms that can reduce our reliance on animal testing and bring better and safer treatments to market faster.

Read more

Aspect Biosystems Awarded Canadian Government NRC-IRAP Funding

Aspect Biosystems Ltd. is pleased to announce that it has been awarded $450,000 CAD in grant funding by the National Research Council-Industry Research Assistance Program (“NRC-IRAP”) to further advance the development of its Lab-on-a-Printer™ platform technology…

Read more

Aspect Biosystems Closes An Oversubscribed Financing

Aspect Biosystems Ltd., a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering, today announced the completion of an oversubscribed financing.

Read more